Milestone Pharmaceuticals
IPO News: Filed S-1: Milestone Pharmaceuticals Files $86.3mm IPO
Milestone Pharmaceuticals

Milestone Pharmaceuticals


Size (mm):  $86.3

Bookrunners:  JEFF | COWEN | PJ

Major Holders: RTW Investments  | Novo Holdings | Fonds de solidarité des travailleurs du Québec | BDC Capital | Venrock | Domain Associates | Pappas Capital | Forbion

Description: Milestone  Pharmaceuticals is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.

Note: Emerging Growth Company

Reference Link: S-1